[FAQ] What is Retatrutide?

AndyG

Administrator
Staff member
May 26, 2024
19
1
Retatrutide is an investigational medication currently under development for the treatment of obesity and type 2 diabetes. It is a novel, once-weekly injectable drug designed to act on multiple hormone pathways to regulate body weight and glucose metabolism.

Mechanism of Action:
Retatrutide is a multi-receptor agonist targeting the receptors for three key hormones:
  1. Glucagon-like peptide-1 (GLP-1): Similar to other GLP-1 receptor agonists, it helps increase insulin secretion, decrease glucagon secretion, slow gastric emptying, and reduce appetite.
  2. Glucose-dependent insulinotropic polypeptide (GIP): Enhances insulin secretion in response to food intake and improves insulin sensitivity.
  3. Glucagon: Involved in increasing energy expenditure and promoting fat breakdown.
By acting on these three receptors, Retatrutide aims to provide a comprehensive approach to managing obesity and type 2 diabetes, potentially offering greater efficacy in weight loss and glycemic control than single-hormone therapies.

Clinical Development:
  • Phase of Development: Retatrutide is in clinical trials, and early studies have shown promising results in terms of significant weight loss and improved blood glucose control.
  • Potential Indications: Obesity and type 2 diabetes management, with ongoing studies to evaluate its safety and efficacy.
Administration:
  • Retatrutide is administered as a once-weekly subcutaneous injection.
Efficacy:
  • Early clinical trial data suggest that Retatrutide may offer significant weight reduction and better control of blood glucose levels compared to existing treatments.
Side Effects:
  • Common side effects observed in clinical trials include gastrointestinal issues such as nausea, vomiting, and diarrhea.
  • As it is still under investigation, the full profile of potential side effects and long-term safety is not yet fully established.
Retatrutide represents a new class of multi-receptor agonists that could potentially revolutionize the treatment landscape for obesity and type 2 diabetes by providing a more effective and comprehensive therapeutic option.
 
Back
Top